• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

通过T细胞受体启动信号转导需要肽/MHC配体的多价结合[已修正]。

Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].

作者信息

Boniface J J, Rabinowitz J D, Wülfing C, Hampl J, Reich Z, Altman J D, Kantor R M, Beeson C, McConnell H M, Davis M M

机构信息

Department of Microbiology and Immunology, Stanford University, California 94305, USA.

出版信息

Immunity. 1998 Oct;9(4):459-66. doi: 10.1016/s1074-7613(00)80629-9.

DOI:10.1016/s1074-7613(00)80629-9
PMID:9806632
Abstract

While much is known about intracellular signaling events in T cells when T cell receptors (TCRs) are engaged, the mechanism by which signaling is initiated is unclear. We have constructed defined oligomers of soluble antigen-major histocompatibility complex (MHC) molecules, the natural ligands for the TCR. Using these to stimulate specific T cells in vitro, we find that agonist peptide/MHC ligands are nonstimulatory as monomers and minimally stimulatory as dimers. Similarly, a partial-agonist ligand is very weakly active as a tetramer. In contrast, trimeric or tetrameric agonist ligands that engage multiple TCRs for a sustained duration are potent stimuli. Ligand-driven formation of TCR clusters seems required for effective activation and helps to explain the specificity and sensitivity of T cells.

摘要

虽然人们对T细胞受体(TCR)参与时T细胞内的信号转导事件了解很多,但信号启动的机制尚不清楚。我们构建了可溶性抗原 - 主要组织相容性复合体(MHC)分子(TCR的天然配体)的特定寡聚体。利用这些寡聚体在体外刺激特定的T细胞,我们发现激动剂肽/MHC配体作为单体无刺激作用,作为二聚体刺激作用最小。同样,部分激动剂配体作为四聚体时活性非常弱。相比之下,能持续与多个TCR结合的三聚体或四聚体激动剂配体是强效刺激物。配体驱动的TCR簇形成似乎是有效激活所必需的,并且有助于解释T细胞的特异性和敏感性。

相似文献

1
Initiation of signal transduction through the T cell receptor requires the multivalent engagement of peptide/MHC ligands [corrected].通过T细胞受体启动信号转导需要肽/MHC配体的多价结合[已修正]。
Immunity. 1998 Oct;9(4):459-66. doi: 10.1016/s1074-7613(00)80629-9.
2
CD8 T cells, like CD4 T cells, are triggered by multivalent engagement of TCRs by MHC-peptide ligands but not by monovalent engagement.与CD4 T细胞一样,CD8 T细胞由MHC-肽配体对TCR的多价结合触发,而非单价结合。
J Immunol. 2006 Feb 1;176(3):1498-505. doi: 10.4049/jimmunol.176.3.1498.
3
Serial TCR engagement and down-modulation by peptide:MHC molecule ligands: relationship to the quality of individual TCR signaling events.肽:MHC分子配体介导的TCR连续结合与下调:与单个TCR信号事件质量的关系
J Immunol. 1999 Feb 15;162(4):2073-80.
4
Two-step binding mechanism for T-cell receptor recognition of peptide MHC.T细胞受体识别肽-MHC的两步结合机制。
Nature. 2002 Aug 1;418(6897):552-6. doi: 10.1038/nature00920.
5
CD8 expression allows T cell signaling by monomeric peptide-MHC complexes.CD8的表达使T细胞能够通过单体肽 - 主要组织相容性复合体进行信号传导。
Immunity. 1998 Oct;9(4):467-73. doi: 10.1016/s1074-7613(00)80630-5.
6
A window of opportunity for cooperativity in the T Cell Receptor.T 细胞受体协同作用的机会之窗。
Nat Commun. 2018 Jul 5;9(1):2618. doi: 10.1038/s41467-018-05050-6.
7
On Peptides and Altered Peptide Ligands: From Origin, Mode of Action and Design to Clinical Application (Immunotherapy).论肽与修饰肽配体:从起源、作用方式与设计到临床应用(免疫疗法)。
Int Arch Allergy Immunol. 2016;170(4):211-233. doi: 10.1159/000448756. Epub 2016 Sep 20.
8
Molecular components of T-cell recognition.T细胞识别的分子成分。
Annu Rev Immunol. 1992;10:835-73. doi: 10.1146/annurev.iy.10.040192.004155.
9
Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation.重组TCR配体诱导早期TCR信号传导及独特的下游激活模式。
J Immunol. 2003 Aug 15;171(4):1934-40. doi: 10.4049/jimmunol.171.4.1934.
10
Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.同源肽-MHC 复合物在病毒感染的细胞中作为紧密相邻的纳米簇表达,以允许 TCR 交联。
J Immunol. 2014 Jan 1;192(1):52-8. doi: 10.4049/jimmunol.1301224. Epub 2013 Dec 4.

引用本文的文献

1
From TCR fundamental research to innovative chimeric antigen receptor design.从T细胞受体基础研究到创新型嵌合抗原受体设计。
Nat Rev Immunol. 2025 Mar;25(3):212-224. doi: 10.1038/s41577-024-01093-7. Epub 2024 Oct 21.
2
Differential roles of kinetic on- and off-rates in T-cell receptor signal integration revealed with a modified Fab'-DNA ligand.Kinetic 上、离解速率在 T 细胞受体信号整合中的差异作用通过一种改良的 Fab'-DNA 配体揭示。
Proc Natl Acad Sci U S A. 2024 Sep 24;121(39):e2406680121. doi: 10.1073/pnas.2406680121. Epub 2024 Sep 19.
3
Ligand requirements for immunoreceptor triggering.
免疫受体触发的配体要求。
Commun Biol. 2024 Sep 13;7(1):1138. doi: 10.1038/s42003-024-06817-y.
4
Mechanical control of antigen detection and discrimination by T and B cell receptors.T 和 B 细胞受体对抗原检测和识别的机械控制。
Biophys J. 2024 Aug 6;123(15):2234-2255. doi: 10.1016/j.bpj.2024.05.020. Epub 2024 May 23.
5
The quantum model of T-cell activation: Revisiting immune response theories.T 细胞激活的量子模型:重新审视免疫反应理论。
Scand J Immunol. 2024 Aug;100(2):e13375. doi: 10.1111/sji.13375. Epub 2024 May 15.
6
Differential Roles of Kinetic On- and Off-Rates in T-Cell Receptor Signal Integration Revealed with a Modified Fab'-DNA Ligand.用改良的Fab'-DNA配体揭示动力学结合和解离速率在T细胞受体信号整合中的不同作用
bioRxiv. 2024 Apr 2:2024.04.01.587588. doi: 10.1101/2024.04.01.587588.
7
The multivalency game ruling the biology of immunity.主宰免疫生物学的多价性博弈。
Biophys Rev (Melville). 2023 Dec 29;4(4):041306. doi: 10.1063/5.0166165. eCollection 2023 Dec.
8
Biomaterials-mediated ligation of immune cell surface receptors for immunoengineering.用于免疫工程的生物材料介导的免疫细胞表面受体连接
Immunooncol Technol. 2023 Dec 10;21:100695. doi: 10.1016/j.iotech.2023.100695. eCollection 2024 Mar.
9
Toward innovative approaches for exploring the mechanically regulated tumor-immune microenvironment.探索机械调节的肿瘤免疫微环境的创新方法
APL Bioeng. 2024 Feb 21;8(1):011501. doi: 10.1063/5.0183302. eCollection 2024 Mar.
10
DNA Nanotechnology for Investigating Mechanical Signaling in the Immune System.DNA 纳米技术在免疫系统机械信号转导研究中的应用。
Angew Chem Int Ed Engl. 2023 Jul 24;62(30):e202302967. doi: 10.1002/anie.202302967. Epub 2023 May 15.